GlassScriptPhysician profile
Pratik Shah
NPI 1871977793
$4,848.44
in general payments reported to CMS, 2019-2025
17 companies · $632 in 2025
The $632 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $338 · 2021: $1,040 · 2022: $992 · 2023: $1,205 · 2024: $640 · 2025: $632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,477.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $732.65 | 2020-2023 | |
| Cequr Corporation | $536.84 | 2023-2025 | Cequr Simplicity |
| Insulet Corporation | $430.12 | 2021-2024 | Omnipod |
| Astrazeneca Pharmaceuticals LP | $417.81 | 2020-2021 | |
| Dexcom, INC. | $395.34 | 2022-2024 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Mannkind Corporation | $350.62 | 2021-2023 | Afrezza |
| Horizon Therapeutics Plc | $332.90 | 2022-2023 | Tepezza |
| Lilly USA, LLC | $247.59 | 2022-2024 | Mounjaro |
| Medtronic, INC. | $235.10 | 2022-2025 | Minimed 780g |
| Corcept Therapeutics | $225.03 | 2022 | |
| Xeris Pharmaceuticals, INC. | $224.17 | 2023-2025 | Recorlev, Gvoke Hypopen |
| Boehringer Ingelheim Pharmaceuticals, INC. | $197.64 | 2021-2022 | |
| Beta Bionics, INC. | $158.17 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Bayer Healthcare Pharmaceuticals INC. | $115.79 | 2023 | |
| Sanofi-Aventis U.S. LLC | $102.27 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $92.79 | 2023 | |
| Zealand Pharma US, INC. | $53.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pratik Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.